Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$5.03B
Total Bought:
$975.21M
Total Sold:
$1.35B
Net Transaction:
-$376.17M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)6,361,3236,219,323-142,000$1.19B$1.28B25.38%+$85.23M
Genmab A/SADS(GMAB)13,133,13114,136,472+1,003,341$360.77M$504.32M10.03%+$143.55M
Edgewise Therapeutics, Inc.(EWTX)10,215,45510,778,665+563,210$415.05M$437.61M8.70%+$22.56M
Spyre Therapeutics, Inc.(SYRE)3,840,7784,457,450+616,672$340.98M$396.85M7.89%+$55.86M
Insmed Incorporated(INSM)1,325,9772,695,977+1,370,000$141.38M$307.72M6.12%+$166.34M
MBX Biosciences, Inc.(MBX)2,508,0153,772,885+1,264,870$138.44M$221.17M4.40%+$82.72M
Oruka Therapeutics, Inc.(ORKA)2,144,5262,493,507+348,981$204.09M$207.68M4.13%+$3.59M
Belite Bio, IncADS(BLTE)1,232,8771,142,123-90,754$189.84M$193.96M3.86%+$4.11M
Tarsus Pharmaceuticals, Inc.(TARS)2,775,6492,301,375-474,274$174.70M$180.91M3.60%+$6.21M
Tango Therapeutics, Inc.(TNGX)6,357,5236,961,546+604,023$198.74M$173.69M3.45%-$25.05M
Viridian Therapeutics, Inc.(VRDN)6,723,7888,257,672+1,533,884$123.52M$170.03M3.38%+$46.51M
BridgeBio Pharma, Inc.(BBIO)02,347,850+2,347,850$0$154.49M3.07%+$154.49M
Vaxcyte, Inc.(PCVX)2,127,8522,142,852+15,000$123.69M$121.93M2.42%-$1.76M
Erasca, Inc.(ERAS)9,550,0007,998,257-1,551,743$174.96M$117.25M2.33%-$57.70M
Jade Biosciences Inc2,857,4056,053,268+3,195,863$63.49M$85.05M1.69%+$21.56M
Tyra Biosciences, Inc.(TYRA)1,828,6073,510,360+1,681,753$58.41M$76.77M1.53%+$18.37M
Olema Pharmaceuticals Inc8,670,5768,720,576+50,000$108.47M$75.35M1.50%-$33.12M
Obsidian Therapeutics Inc04,155,214+4,155,214$0$57.05M1.13%+$57.05M
Structure Therapeutics IncADS01,299,199+1,299,199$0$40.63M0.81%+$40.63M
Achieve Life Science Inc4,951,8564,951,8560$32.34M$40.06M0.80%+$7.72M
Veradermics, Incorporated(MANE)0310,060+310,060$0$37.59M0.75%+$37.59M
Assembly Biosciences Inc1,553,7481,553,7480$42.70M$36.50M0.73%-$6.20M
Oric Pharmaceuticals Inc01,505,769+1,505,769$0$20.28M0.40%+$20.28M
Korsana Biosciences Inc0613,914+613,914$0$19.65M0.39%+$19.65M
Editas Medicine Inc5,586,6257,575,140+1,988,515$18.10M$19.47M0.39%+$1.37M
Hemab Therapeutics Hldgs Inc0629,347+629,347$0$19.41M0.39%+$19.41M
Vor Biopharma Inc.(VOR)1,750,000889,575-860,425$32.22M$16.97M0.34%-$15.24M
Kardigan Inc900,000900,0000$21.46M$13.28M0.26%-$8.19M
Tcgx Acquisition CorpCL A0300,000+300,000$0$3.75M0.07%+$3.75M
Inventiva SaADS4,000,000808,176-3,191,824$15.12M$2.98M0.06%-$12.14M
Alnylam Pharmaceuticals, Inc.(ALNY)480,0000-480,000$144.49M$0—-$144.49M
Apogee Therapeutics Inc1,576,3850-1,576,385$209.23M$0—-$209.23M
EyePoint, Inc.(EYPT)2,890,3970-2,890,397$41.33M$0—-$41.33M
Lexeo Therapeutics, Inc.(LXEO)4,175,3820-4,175,382$19.44M$0—-$19.44M
MapLight Therapeutics, Inc.(MPLT)685,8520-685,852$24.58M$0—-$24.58M
Nuvalent Inc5,924,4330-5,924,433$731.67M$0—-$731.67M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q3 2026 | TickerTrail